Jenny Gross

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

Secondary Somatic Mutations Restoring<i>BRCA1/2</i>Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Barbara M. Norquist, Kaitlyn Wurz, Christopher C. Pennil et al. · Journal of Clinical Oncology · 2011 · 573 citations · Full text

Medicine, Genetics, Oncology +17

Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer

Lei Zhang, Hua Xiao, Scott Karlan et al. · PLoS ONE · 2010 · 272 citations · Full text

Dentistry, Cancer Biology, Proteomics +16

Common variants at 19p13 are associated with susceptibility to ovarian cancer

Kelly L. Bolton, Jonathan P. Tyrer, Honglin Song et al. · Nature Genetics · 2010 · 257 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog et al. · Cancer Research · 2010 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17